InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Litvack Frank, 董事. Officer active across 1 company, notably Capricor Therapeutics, INC.. Aggregated, 6 reports have been recorded. Activity tracked since 3 January 2022. The latest transaction was filed on 13 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Litvack Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
3,937 股@ US$1.390.0013% mcap1.2% 占其流量Common StockSEC:0001310715-26-000004:0
25,000 股@ US$1.396.9% 占其流量Common StockSEC:0001415889-25-006736:0
20,391 股@ US$1.104.4% 占其流量Common StockSEC:0001415889-24-028337:0
20,748 股@ US$1.395.4% 占其流量Common StockSEC:0001415889-23-012326:0
14,027 股@ US$1.393.8% 占其流量Common StockSEC:0001415889-23-003083:0
154,543 股@ US$1.3964.5% 占其流量Common StockSEC:0001415889-22-000284:0
6 条申报中的 6 条
About Litvack Frank
Litvack Frank is Administrateur at Capricor Therapeutics, INC. (XNAS). The record shows 6 filings in total, and the 6 sampled filings cover the period from 2022-01-04 to 2026-05-14, with a modal transaction nature listed as Levée d'options.
